Header Logo

Connection

SETH LERNER to Ribonucleotide Reductases

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Ribonucleotide Reductases.
SETH LERNER
Connection Strength
0.021
Ribonucleotide Reductases
  1. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Mol Cancer Ther. 2009 Jul; 8(7):1772-8.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.